Calyx Law | Media

MEDIA

RECENT APPEARANCES:

Podcast Guest, The Psychedelic Patent Puzzle, The Psychedelic Podcast by Third Wave, May 22, 2023
Presenter, Psychedelic Patents: Avoiding Controversy While Achieving Defensible and Enforceable IP, May 16, 2023
Podcast Interviewee, Law360 Explores: Psychedelics, May 15, 2023
Workshop Leader (with G. Dwulet), Psychedelics & Patents: Different Views Through the Looking-Glass, May 14, 2023
Moderator, Equity & Inclusion in the Psychedelic Community, Entheo Society, April 29, 2023
Panelist, Psychedelic Intellectual Property Roundtable Series: Part 1, H.C. Wainwright & Co., April 17, 2023
Panelist (Chris Byrnes), Thinking Beyond Utilitarianism, Race + IP Conference, April 15, 2023
Panelist, Building an Equitable Psychedelic Medicines System, SXSW, March 10, 2023
Presenter, Dead on Arrival? Discussion With an Expert on Psychedelic Medicine IP, EF Hutton, Feb. 27, 2023
Podcast Guest, Patents, Regulations & REMS...Oh my!, Your Brain on Science, Jan. 31, 2023
Podcast Guest, Patent Law & Psychedelics, Two Brad for You, Jan. 31, 2023
Presenter, Legal & Regulatory Landscape for Psychedelics: Protecting IP, TSG Live Webcast, Jan. 12, 2023
Panelist (with C. Alvarez), Incentives, Investment, & Innovation: Optimizing for Success, Wonderland, Nov. 4, 2022
Lecturers (C. Byrnes, G. Pechenik & C. Alvarez), IP, Sacred Plants & Indigenous Rights, Chacruna, Oct. 10, 2022
Panelist, Navigating the Controversial IP Landscape, Microdose Psychedelic Capital, Sept. 29, 2022
Panelist, Psychedelic Pasts, Presents, & Futures, UW-Madison Borghesi-Mellon Roundtable, Sept. 27, 2022
Podcast Guest, Psychedelic Patents & Law, Psychoactive with Ethan Nadelmann, Sept. 21, 2022
Guest Lecturer, Who Owns the Healing Power of Psychedelics?, Instituto Phaneros, Sept. 13, 2022
Presenter, Promoting Innovation & Ethically Protecting IP, Psychedelic Law Summit, Sept. 8, 2022
Panelist, Overcoming Roadblocks: Making Psychedelic-Assisted Therapy a Reality, ICPR, Aug. 31, 2022
Podcast Guest (Chris Byrnes), End of the Road: Episode 235, Michael Kokal, August 29, 2022
Moderator, Who Put the DEA in Charge of Psychedelic Regulation..., Chacruna, August 19, 2022
Guest Lecturer, Decriminalization, Legalization & Future of Psychedelics, Stanford LAW107W, Aug. 11, 2022
Webinar Guest, Psychedelic Patenting, California Psychedelic Bar Association, August 7, 2022
Moderator, Indigenous Knowledge & Patent Law Roundtable, Porta Sophia ARN Kickoff, June 3, 2022
Panelist, Psychedelic Capitalism...Creating a Regenerative Renaissance, Plant Spirit Summit, May 27, 2022
Presenters (with C. Alvarez), IP, Traditional Knowledge, & Open Science, CIIS Guest Lecture, April 25, 2022
Panelist, EU Psychedelics Legalization & Legislation, Plant Medicine Week Conference, April 7, 2022
Panelists, Groovy or Square? Patenting Psychedelics, Pot & Plant Medicines, ACS Spring, Mar. 20, 2022
Podcast Interviewee, Set & Setting: Part II, Maia Laperle, March 2, 2022
Presenter, LSD IP: Tripping Over the Patent Landscape?, Microdose: LSD Conference, Feb. 17, 2022
Host, Equity & Public Participation in Psychedelic Patents: with Priti Krishtel, Chacruna, Feb. 16, 2022
Presenter, Legal & Regulatory Landscape for Psychedelics: Protecting IP, TSG Live Webcast, Jan. 26, 2022
Panelists, Everything You Ever Wanted To Know About Psychedelic Patents and IP, Jan. 19, 2022
Presenter, Can We Have a Psychedelic Patent System?, Horizons NYC, Dec. 4, 2021
Panelist, Patent Wars, Microdose Wonderland Conference, Miami, Nov. 9, 2021
Presenter, Patents, Ownership, & Commercialization, Int'l Psilocybin Symposium, Sept. 21, 2021
Panelist (Chris Byrnes), Psychedelic Patents May be Bad for Your Health, Chacruna, Sept. 15, 2021
Presenter, Psychedelic Patents: Tripping Over a New Patent Landscape?, CLE Comp., Sept. 13, 2021
Panelist, Psychedelic Ethics: Patents, Patients & DMT, Microdose: DMT Conference, Sept. 10, 2021
Panelist, Intellectual Property in Psychedelic and Alternative Medicine, Chacruna, Sept. 1, 2021
Presenter, Cannabis IP—All You Need to Know, Plants to Plants Webinar Series, Aug. 31, 2021
Interviewee, The Forefront of Cannabis Business 2022 (forthcoming documentary), Aug. 28, 2021
Presenter, What a Long Strange (Legal) Trip It’s Been, SF Bar Assoc., August 17, 2021
Presenter, IP in Psychedelics & Oregon’s Psilocybin Services Act, Oregon State Bar, Aug. 3, 2021
Presenter, Exploring Therapeutic Uses of Psychedelic Substances, Am. Bar Assoc., July 27, 2021
Podcast Guest, Vine Ventures, July 6, 2021
Presenter, IP in the Business of Cannabis & Psychedelics, American Chemical Soc'y, June 7, 2021
Panelist, Psychedelic Monopoly: Patenting & Ownership, Psych. Soc’y UK, Chacruna, May 18, 2021
Panelist, Patenting Psychoactives, LSPN Connect, May 13, 2021
Podcast Guest, Analyzing the Atai Life Sciences IPO, Business Trip, May 7, 2021
Panelist, What’s Next for Cannabis, Hemp, & Psychedelics?, CannaLaw Summit, May 6, 2021
Podcast Guest, Psychedelic Intellectual Property, Living Mirrors, April 27, 2021
Moderator, The Past, Present, & Future of Psychedelics, Planet MicroCap Showcase, April 20, 2021
Podcast Guest, The IP of Consciousness, How to Launch an Industry, April 9, 2021
Panelist, Ethical IP for Psychedelics?, Microdose Psychedelic Insights, March 31, 2021
Panelist, Awakening: An Exploration of Plant Medicine, Plant Media Project, Dec. 9, 2020
Panelist, Patent Law for Psychedelic Medicine, Business Trip, Dec. 9, 2020
Presenter, Psychedelic-Assisted Therapy Meets Patent Rights, Nat’l Academy CLE, Nov. 25, 2020
Panelist, Mushroom Masterclass: Law & Regulation, Microdose Psych. Insights, Nov. 20, 2021
Podcast Guest, Graham Pechenik, the Founder of Calyx Law, The Vine, Episode #13, Nov. 12, 2020
Podcast Guest, Who Owns Psychedelics, New Amsterdam Psychedelic Law, Nov. 4, 2020

RECENT COVERAGE:

Quoted, Psychedelics Companies Face Quandary In Protecting IP, Law360, May 16, 2023
Quoted, What’s the Future of Psychedelic Intellectual Property?, Lucid News, March 3, 2023
Quoted (Chris Byrnes), Do Psychedelics Demand an Innovative Approach to Patents?, Lucid News, March 2, 2023
Quoted, With a patent application, St. Joseph's Univ. lab looks to invent..., The Philadelphia Inquirer, Feb. 27, 2023
Cited, Industry Report: Controversies Surrounding Psychedelic Patents, Water Tower Research, Feb. 2, 2023
Quoted, Mindset Granted Patent for Lead Drug (But Reunion Also Has Patent), Microdose, Jan. 20, 2023
Quoted, Psychedelics Are Surging—at the Expense of Indigenous Communities, Daily Beast, Dec. 24, 2022
Included, The Best Cannabis Lawyers in San Francisco, CNBS, Dec. 7, 2022
Quoted, Dawn of Decentralized Science, Under the Palm, Nov. 18, 2022
Quoted (Chris Byrnes), A Look at Web3 and Psychedelic IP, Microdose, Oct. 13, 2022
Included, Beyond Michael Pollan: Where to Learn More About Psychedelics, Marc Gunther, Sept. 19, 2022
Included, World Class Leaders in Psychedelics Form Benzinga’s Psychedelic…, Benzinga, Aug. 30, 2022
Quoted, The Drug Enforcement Agency Listens to Psychedelic Experts, Drug Science, Aug. 5, 2022
Quoted (Celeste Alvarez), This Week in Psychedelics: Patent Ping Pong, Microdose, July 29, 2022
Quoted, Special Report: Inside the Challenge to DEA's Proposed Scheduling, Psych. Alpha, July 29, 2022
Quoted, DEA Reverses Scheduling of Five Novel Psychedelic Compounds, Psych. Today, July 28, 2022
Quoted, Psychedelic Rx: Legal Battles Aim to Expand Patients' Access..., ABA Journal, July 27, 2022
Quoted, The High-Stakes Race to Engineer New Psychedelic Drugs, Wired, July 26, 2022
Quoted, DEA Revokes Project to Schedule 5 New Psychedelic Compounds, Benzinga, July 25, 2022
Quoted, DEA Cancels Proposed Ban of Five Psychedelics..., Marijuana Moment, July 25, 2022
Quoted, Breaking News: DEA Reverses Decision to Ban 5 Psychedelics, Microdose, July 23, 2022
Quoted, Psychedelics Provide New Frontier For Venture Funding..., Crunchbase, July 19, 2022
Quoted, The Battle for Psychedelic Patents, Psychedelic Spotlight, July 11, 2022
Quoted, Compass Pathways Psilocybin Patent Upheld, Psychedelic Spotlight, June 24, 2022
Quoted, This Week in Psychedelics: “Candyflipping,” a non-hallucinogenic..., The Microdose June 24, 2022
Quoted, Judges Deny Challenge to Psilocybin Patent, VICE, June 23, 2022
Quoted, This Week in Psychedelics: Patenting Psilocybin for Cancer Patients, The Microdose, May 27, 2022
Quoted, Patents In The Psychedelics Space:...Here's What The Experts Say, Benzinga, May 20, 2022
Quoted, A New Database Seeks to Prevent “Bad” Psychedelic Patents, Lucid News, April 25, 2022
Quoted, Can the Clever Use of Old Legal Strategies Thwart Psychedelic Monopolies?, VICE, Apr, 14, 2022
Quoted, The Brave New World of Legalized Psychedelics Is Already Here, The Nation, March 19, 2022
Quoted, A Complex Patent & Pricing Picture: Regulating Psychedelics, Pharma. Exec., March 9, 2022
Included, Interested In Psychedelics? 30 Accounts You Should Follow On Twitter, TDR, Feb. 23, 2022
Quoted, Patent trolls beware! This lawyer is tracking every application..., Vancouver Sun, Feb. 18, 2022
Profiled, Beware the Psychedelic Patent Trolls: Meet the Lawyer..., The GrowthOp, Feb. 14, 2022
Quoted, This Week in Psychedelics: A DMT Vape Pen Patent, The Microdose, Feb. 4, 2022
Quoted, DEA Moves to Outlaw Five Tryptamines, The Microdose, UC Berkeley Newsltr, Jan. 28, 2022
Quoted, This Week in Psychedelics: Psychedelic Patent Applications, The Microdose, Jan. 14, 2022
Quoted, Rollups: The Emerging Magic Mushroom Monopoly, The American Prospect, Jan. 10, 2022
Quoted, Should Psychedelics Be Patented?, Freethink, Dec. 29, 2021
Quoted, An Infamous Psilocybin Patent Has Just Been Challenged, VICE, Dec. 15, 2021
Profiled, 5 Questions for Graham Pechenik, The Microdose, UC Berkeley Newsletter, Dec. 13, 2021
Quoted, The Future of Psychedelics Industry Hinges on Patents, Business Insider, Nov. 19, 2021
Quoted, Latest Psilocybin Patent Highlights Swirling Battle Over Psychedelics IP, STAT, Oct. 26, 2021
Quoted, The ‘Shroom Boom’: The Meteoric Rise of the Psychedelic Medicine Industry, STAT Reports
Quoted, Psychedelic Patents: Nature, IP Law, & Exclusion, Truffle Report, Sept. 22, 2021
Cited, POPLAR: Harvard’s Psychedelic Law, Policy Initiative, Truffle Report, Aug. 10, 2021
Quoted, J&J's Janssen Denied Data Protection Rights For Spravato, Benzinga, Aug. 9, 2021
Quoted, COMPASS Pathways’ Psilocybin Patent Questioned, Psymposia, Aug. 5, 2021
Cited, Are Psychedelics Legal In The US? A Deep Dive Into The Legal Status, Benzinga, July 20, 2021
Quoted, Peter Thiel–Backed Startup Trying to Monopolize Astral Plane?, Mother Jones, July 6, 2021
Quoted, LSD to Treat Food Allergies? Company Receives Patent..., SnackSafely.com, July 5, 2021
Quoted, Experts Share How a Brewing Fight Could Shape the Future, Business Insider, June 2, 2021
Quoted, Can LSD Treat Food Allergies? We Don’t Know, But It’s Been Patented, VICE, July 1, 2021
Quoted, Psychedelic Intellectual Property, Reality Sandwich, May 13, 2021
Included, 100 Most Influential People in Psychedelics, Psychedelic Invest, May 1, 2021
Profiled, The 100 Most Influential People in Psychedelics, Psychedelic Invest, April 30, 2021
Quoted, Psychedelics Experts Discuss the Sector’s Ongoing Patent Debate, April 26, 2021
Quoted, There’s a Land Grab for Psychedelic Patents, Psychedelic Times, April 19, 2021
Quoted, Is it Possible to Create an Ethical Psychedelics Company?, VICE, April 6, 2021
Quoted, Psychedelic Monopoly: A Discussion on the Patent Race, Truffle Report, May 29, 2021
Cited, These 24 Psychedelic Patents Are Paving Way For Medicine 2.0, Benzinga, March 22, 2021
Quoted, COMPASS Pathways Is Trying to Patent Psilocybin, Psymposia, March 18, 2021
Quoted, Psyched: The Patents Dilemma, Benzinga, March 15, 2021
Quoted, Investors Debating Who Should Own the Future of Psychedelics, VICE, March 10, 2021
Cited, The Psilocybin Patent Race is On, Real Money, March 6, 2021
Quoted, The Race to Patent Psychedelics is Just Getting Started, VICE, March 5, 2021
Quoted, Where Profit-Motives & Psychedelics Meet, The Psychedelic Renaissance, Feb. 27, 2021
Quoted, Cannabinoids in Focus after GW Pharma Snapped Up, Labiotech.eu, Feb. 18, 2021
Quoted, Can a Company Patent the Basic Components of Psych. Therapy?, VICE, Feb., 9, 2021
Quoted, Cannabis Patents Can Protect Intellectual Property, Stratcann, Feb. 5, 2021
Profiled, Meet G. Pechenik: Cannabis & Psychedelics Patent Attorney, Shoutout LA, Jan. 11, 2021
Cited, Ethical Concerns about Psilocybin Intellectual Property, ACS Pharmacology, Jan. 1, 2021
Quoted, Canopy’s GW Pharma Lawsuit Trouble for Extractors, Mugglehead, Dec. 24, 2020
Profiled, Five Psychedelic Law Firms You Should Have on Your Radar, Psych. Invest, Nov. 13, 2020
Quoted, COMPASS Continues Attempts to Build Psychedelic Monopoly, Psymposia, Sept. 15, 2020

RECENT WRITING:

Psychedelic Industry Report (contributor), Microdose, Aug. 21, 2022
Pay-For-Success Contracts: An Open Source Alternative to Psychedelic Patents (with Savva Kerdemelidis, Celeste Alvarez, & Chris Byrnes), Microdose, Aug. 8, 2022
Letters to the Editor: Save America’s Patent System (contributor), I-MAK, May 24, 2022
Co-Creating a Psychedelic Commons: A Commoner’s Guide (with Chris Byrnes), Chacruna, Feb. 14, 2022
Can We Have a Psychedelic Patent System? (with Chris Byrnes), MAPS Bulletin Vol. 31, No. 2, Aug. 26, 2021
Special Report: IP & Patents for the Psychedelic Industry (contributor), Microdose, March 9, 2021
FRENS: A Generalizable Legal Framework for Fractionalized IP-NFTs (Chris Byrnes), VitaDAO, Feb. 4, 2022

calyxlaw

MEDIA

< BACK